SEARCH RESULTS

IT – Astrazeneca v. Teva / Fulvestrant

Astrazeneca vs. Teva, Court of Milan, 24 December 2020, docket number 8782/2020 The last available decision on Fulvestrant in Italy was handed down by the Court of Milan on 24 December 2020, which held invalid/ineffective three patents of AstraZeneca. With a detailed and extensive reasoning, the Court declared EP’573 invalid for lack of inventive step, […]

FOUND IN: BLOG

ES – Fulvestrant / Court of Appeals of Barcelona

ES – Fulvestrant / Court of Appeals of Barcelona, 19 November 2019, Docket Nos. 240/2019 & 505/2019 In two separate orders, both issued on 19 November 2019, the Barcelona Court of Appeals confirmed the dismissal of a preliminary injunction decided by Orders of 18 July 2018, upon request of ASTRANEZECA against TEVA PHARMA S.L.U. (TEVA) […]

FOUND IN: BLOG

DE – AstraZeneca v. Hexal – fulvestrant and 2nd medical use

AstraZeneca AB vs. Hexal AG, Court of Appeal Düsseldorf, docket no. I-2 U 29/18, with thanks to Cordula Schumacher, ARNOLD RUESS, for sending in the decision, translation and a headnote *** Now including an English translation *** The Düsseldorf Court of Appeal further specifies how to deal with 2nd medical use claims. The case dealt with […]

FOUND IN: BLOG

NL – Astrazeneca v. Sandoz / Fulvestrant / Appeal

Astrazeneca AB v. Sandoz B.V., Court of Appeal The Hague, The Netherlands, 27 November 2018, Case no. 200.237.828/01, with thanks to Willem Hoyng and Theo Blomme, HOYNG ROKH MONEGIER, for sending in the case The Court of Appeal of The Hague has upheld AstraZeneca’s patents EP 1 250 138 B2 and EP 2 255 573 […]

FOUND IN: BLOG